|
End-of-day quote
Taipei Exchange
06/10/2026
|
5-day change | 1st Jan Change | ||
| 46.90 TWD | -0.21% |
|
+0.32% | -8.58% |
Company Valuation: Sagittarius Life Science Corp
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Market Cap 1 | 1,113 | 895 | 1,325 | 1,699 | 1,040 | 3,465 |
| Change | - | -19.59% | 48% | 28.26% | -38.79% | 233.24% |
| Enterprise Value (EV) 1 | 756.5 | 564.1 | 1,066 | 1,497 | 889.7 | 2,662 |
| Change | - | -25.43% | 89.02% | 40.38% | -40.56% | 199.19% |
| P/E | -15.1x | -10.4x | -17.9x | -30.9x | -21.4x | -55.9x |
| PBR | 1.9x | 1.73x | 3x | 3.3x | 2.55x | 3.32x |
| PEG | - | -0.6x | 1.3x | 1.2x | 1.8x | 1.5x |
| Capitalization / Revenue | 1.99x | 1.52x | 2.5x | 3.86x | 2.22x | 10x |
| EV / Revenue | 1.36x | 0.96x | 2.02x | 3.4x | 1.9x | 7.69x |
| EV / EBITDA | -12.3x | -6.9x | -14.2x | -25.9x | -15.8x | -50.1x |
| EV / EBIT | -10.5x | -6.27x | -13x | -23.3x | -14.5x | -45.5x |
| EV / FCF | -13.8x | -36.4x | -21.2x | -53.1x | -25.6x | -130x |
| FCF Yield | -7.23% | -2.75% | -4.72% | -1.88% | -3.9% | -0.77% |
| Dividend per Share 2 | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - |
| EPS 2 | -2.272 | -2.655 | -2.28 | -1.691 | -1.491 | -0.9184 |
| Distribution rate | - | - | - | - | - | - |
| Net sales 1 | 558.2 | 587.6 | 529.1 | 440.5 | 467.8 | 346.1 |
| EBITDA 1 | -61.61 | -81.73 | -74.85 | -57.68 | -56.16 | -53.16 |
| EBIT 1 | -71.8 | -90.01 | -82.23 | -64.38 | -61.56 | -58.51 |
| Net income 1 | -74.12 | -86.42 | -74.2 | -55.04 | -48.53 | -49.56 |
| Net Debt 1 | -356.6 | -330.9 | -258.4 | -202.1 | -150.1 | -803.2 |
| Reference price 2 | 34.20 | 27.50 | 40.70 | 52.20 | 31.95 | 51.30 |
| Nbr of stocks (in thousands) | 32,546 | 32,546 | 32,546 | 32,546 | 32,546 | 67,546 |
| Announcement Date | 31/03/21 | 31/03/22 | 31/03/23 | 21/03/24 | 27/03/25 | 30/03/26 |
1TWD in Million2TWD
Estimates
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | - | - | - | 98.66M | |
| 19.86x | 2.72x | 13.59x | 4.16% | 233B | |
| 18.47x | 2.4x | 14.32x | 3.47% | 75.79B | |
| 15.87x | 1.65x | 9.4x | 3.99% | 42.32B | |
| 15.06x | 0.54x | 9.65x | 2.56% | 39.2B | |
| 36.6x | 3.16x | 18.4x | 1.01% | 32.27B | |
| 19.41x | 2.97x | 12.09x | 3.6% | 32.22B | |
| 25.03x | 5.24x | 16.69x | 3.35% | 28.39B | |
| 61.15x | 9.39x | 38.93x | 1.24% | 26.33B | |
| Average | 26.43x | 3.51x | 16.63x | 2.92% | 56.64B | |
| Weighted average by Cap. | 22.41x | 2.95x | 14.74x | 3.49% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- 3205 Stock
- Valuation Sagittarius Life Science Corp
Select your edition
All financial news and data tailored to specific country editions
